PSA

Standard prostate cancer test faces debate

The prostate-specific antigen (PSA) procedure, the most preferred cancer screening test for men has come under the cloud after its discoverer Richard Ablin from the University of Arizona, pointed out that it is not only expensive but useless and actually harmful.

ACS calls for education about after-effects of cancer screening

Latest guidelines for prostrate cancer screening issued by the American Cancer Society (ACS) say patients should be informed about the dangers and advantages of test before they undergo it.

Experimental prostate cancer drug promising

California, April 8: A new drug with a radically different approach towards prostate malignancies may help fight prostate cancer better, researchers reported on Tuesday.